This topic contains a solution. Click here to go to the answer

Author Question: The process for filing a motion to value collateral usually requires the debtor to obtain a hearing ... (Read 68 times)

lunatika

  • Hero Member
  • *****
  • Posts: 548
The process for filing a motion to value collateral usually requires the debtor to obtain a hearing date from the court and provide the creditor(s) with at least ________ days' notice of the hearing date.
 
  A) 30
  B) 21
  C) 12
  D) 90

Question 2

After a proof of claim is filed, the court considers its contents ________ evidence of the creditor's claim.
 
  A) Prima facie
  B) Prima vera
  C) Clear and convincing
  D) Circumstantial



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nathang24

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

B

Answer to Question 2

A




lunatika

  • Member
  • Posts: 548
Reply 2 on: Aug 3, 2018
YES! Correct, THANKS for helping me on my review


sultana.d

  • Member
  • Posts: 320
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library